{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T20:31:38Z","timestamp":1768595498460,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,24]]},"DOI":"10.7759\/cureus.97712","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:01:43Z","timestamp":1764050503000},"source":"Crossref","is-referenced-by-count":1,"title":["Refractory Penile Condyloma Acuminatum in an Elderly Man Receiving Vedolizumab and Azathioprine"],"prefix":"10.7759","author":[{"given":"Sohei","family":"Iwagami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Miyai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Nishihata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-39","article-title":"Systematic review of the incidence and prevalence of genital warts","volume":"13","author":"Patel H","year":"2013","unstructured":"Patel H, Wagner M, Singhal P, Kothari S. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis. 2013, 13:39. 10.1186\/1471-2334-13-39","journal-title":"BMC Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2022.03.004","article-title":"Asian guidelines for condyloma acuminatum","volume":"28","author":"Sindhuja T","year":"2022","unstructured":"Sindhuja T, Bhari N, Gupta S. Asian guidelines for condyloma acuminatum. J Infect Chemother. 2022, 28:845-52. 10.1016\/j.jiac.2022.03.004","journal-title":"J Infect Chemother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02589-13","article-title":"Immunosuppression facilitates the reactivation of latent papillomavirus infections","volume":"88","author":"Maglennon GA","year":"2014","unstructured":"Maglennon GA, McIntosh PB, Doorbar J. Immunosuppression facilitates the reactivation of latent papillomavirus infections. J Virol. 2014, 88:710-6. 10.1128\/JVI.02589-13","journal-title":"J Virol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvr.2023.200268","article-title":"The human Papillomavirus twilight zone - latency, immune control and subclinical infection","volume":"16","author":"Doorbar J","year":"2023","unstructured":"Doorbar J. The human Papillomavirus twilight zone - latency, immune control and subclinical infection. Tumour Virus Res. 2023, 16:200268. 10.1016\/j.tvr.2023.200268","journal-title":"Tumour Virus Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2019.01.010","article-title":"Genital infections due to the human papillomavirus","volume":"37","author":"Sendagorta-Cud\u00f3s E","year":"2019","unstructured":"Sendagorta-Cud\u00f3s E, Burgos-Cibri\u00e1n J, Rodr\u00edguez-Iglesias M. Genital infections due to the human papillomavirus. Enferm Infecc Microbiol Clin (Engl Ed). 2019, 37:324-34. 10.1016\/j.eimc.2019.01.010","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(10)70190-0","article-title":"Factors affecting transmission of mucosal human papillomavirus","volume":"10","author":"Veldhuijzen NJ","year":"2010","unstructured":"Veldhuijzen NJ, Snijders PJ, Reiss P, et al.. Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis. 2010, 10:862-74.","journal-title":"Lancet Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI16432","article-title":"CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes","volume":"111","author":"Tiede I","year":"2003","unstructured":"Tiede I, Fritz G, Strand S, et al.. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest. 2003, 111:1133-45. 10.1172\/JCI16432","journal-title":"J Clin Invest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i18.3240","article-title":"Thiopurine use associated with reduced B and natural killer cells in inflammatory bowel disease","volume":"23","author":"Lord JD","year":"2017","unstructured":"Lord JD, Shows DM. Thiopurine use associated with reduced B and natural killer cells in inflammatory bowel disease. World J Gastroenterol. 2017, 23:3240-51. 10.3748\/wjg.v23.i18.3240","journal-title":"World J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107031","article-title":"The effect of azathioprine on gammaglobulin synthesis in man","volume":"51","author":"Levy J","year":"1972","unstructured":"Levy J, Barnett EV, MacDonald NS, Klinenberg JR, Pearson CM. The effect of azathioprine on gammaglobulin synthesis in man. J Clin Invest. 1972, 51:2233-8. 10.1172\/JCI107031","journal-title":"J Clin Invest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02057-21","article-title":"Antiviral CD19+CD27+ memory B cells are associated with protection from recurrent asymptomatic ocular herpesvirus infection","volume":"96","author":"Dhanushkodi NR","year":"2022","unstructured":"Dhanushkodi NR, Prakash S, Srivastava R, et al.. Antiviral CD19+CD27+ memory B cells are associated with protection from recurrent asymptomatic ocular herpesvirus infection. J Virol. 2022, 96:e0205721. 10.1128\/jvi.02057-21","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan BG","year":"2013","unstructured":"Feagan BG, Rutgeerts P, Sands BE, et al.. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013, 369:699-710. 10.1056\/NEJMoa1215734","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16060","article-title":"Long-term safety of vedolizumab for inflammatory bowel disease","volume":"52","author":"Loftus EV Jr","year":"2020","unstructured":"Loftus EV Jr, Feagan BG, Panaccione R, et al.. Long-term safety of vedolizumab for inflammatory bowel disease. Aliment Pharmacol Ther. 2020, 52:1353-65. 10.1111\/apt.16060","journal-title":"Aliment Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002961","article-title":"Comparative risk of serious infection with vedolizumab vs anti-tumor necrosis factor in inflammatory bowel disease: results from nationwide Swedish registers","volume":"119","author":"Karlqvist S","year":"2024","unstructured":"Karlqvist S, Sachs MC, Eriksson C, et al.. Comparative risk of serious infection with vedolizumab vs anti-tumor necrosis factor in inflammatory bowel disease: results from nationwide Swedish registers. Am J Gastroenterol. 2024, 119:2480-92. 10.14309\/ajg.0000000000002961","journal-title":"Am J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.17235\/reed.2022.9121\/2022","article-title":"Varicella zoster virus encephalitis: a potentially serious complication during treatment with vedolizumab","volume":"115","author":"Celada-Sendino M","year":"2023","unstructured":"Celada-Sendino M, Carballo-Folgoso L, de Francisco R, P\u00e9rez-Mart\u00ednez I, Casta\u00f1o-Garc\u00eda A, Riestra S. Varicella zoster virus encephalitis: a potentially serious complication during treatment with vedolizumab. Rev Esp Enferm Dig. 2023, 115:271-2. 10.17235\/reed.2022.9121\/2022","journal-title":"Rev Esp Enferm Dig"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/IJCIIS.IJCIIS_92_20","article-title":"Iatrogenic Kaposi's sarcoma unmasked by vedolizumab in a patient with ulcerative colitis and well-controlled human immunodeficiency virus: a case report","volume":"11","author":"Ajao SO","year":"2021","unstructured":"Ajao SO, Jayasingam R, Shaaban H. Iatrogenic Kaposi's sarcoma unmasked by vedolizumab in a patient with ulcerative colitis and well-controlled human immunodeficiency virus: a case report. Int J Crit Illn Inj Sci. 2021, 11:177-80. 10.4103\/IJCIIS.IJCIIS_92_20","journal-title":"Int J Crit Illn Inj Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izac056","article-title":"Vedolizumab antagonizes MAdCAM-1-dependent human placental cytotrophoblast adhesion and invasion in vitro","volume":"28","author":"Blaisdell A","year":"2022","unstructured":"Blaisdell A, Zhou Y, Kattah MG, Fisher SJ, Mahadevan U. Vedolizumab antagonizes MAdCAM-1-dependent human placental cytotrophoblast adhesion and invasion in vitro. Inflamm Bowel Dis. 2022, 28:1219-28. 10.1093\/ibd\/izac056","journal-title":"Inflamm Bowel Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6793-7-10","article-title":"Inflammatory cytokines induce MAdCAM-1 in murine hepatic endothelial cells and mediate alpha-4 beta-7 integrin dependent lymphocyte endothelial adhesion in vitro","volume":"7","author":"Ando T","year":"2007","unstructured":"Ando T, Langley RR, Wang Y, Jordan PA, Minagar A, Alexander JS, Jennings MH. Inflammatory cytokines induce MAdCAM-1 in murine hepatic endothelial cells and mediate alpha-4 beta-7 integrin dependent lymphocyte endothelial adhesion in vitro. BMC Physiol. 2007, 7:10. 10.1186\/1472-6793-7-10","journal-title":"BMC Physiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.3.1908","article-title":"MAdCAM-1 expressing sacral lymph node in the lymphotoxin beta-deficient mouse provides a site for immune generation following vaginal herpes simplex virus-2 infection","volume":"173","author":"Soderberg KA","year":"2004","unstructured":"Soderberg KA, Linehan MM, Ruddle NH, Iwasaki A. MAdCAM-1 expressing sacral lymph node in the lymphotoxin beta-deficient mouse provides a site for immune generation following vaginal herpes simplex virus-2 infection. J Immunol. 2004, 173:1908-13. 10.4049\/jimmunol.173.3.1908","journal-title":"J Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7184.192128","article-title":"Zoon balanitis: a comprehensive review","volume":"37","author":"Dayal S","year":"2016","unstructured":"Dayal S, Sahu P. Zoon balanitis: a comprehensive review. Indian J Sex Transm Dis AIDS. 2016, 37:129-38. 10.4103\/0253-7184.192128","journal-title":"Indian J Sex Transm Dis AIDS"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/434944-refractory-penile-condyloma-acuminatum-in-an-elderly-man-receiving-vedolizumab-and-azathioprine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:01:44Z","timestamp":1764050504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/434944-refractory-penile-condyloma-acuminatum-in-an-elderly-man-receiving-vedolizumab-and-azathioprine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.97712","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,24]]}}}